Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-02
2011-08-02
Krass, Frederick (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07989452
ABSTRACT:
The present invention relates to stable and highly purified stable hydralazine hydrochloride compositions and stable hydralazine-containing pharmaceutical compositions. A sterile aqueous injectable pharmaceutical composition suitable for parenteral administration is described comprising a therapeutically effective dose of hydralazine hydrochloride in a pharmaceutically acceptable carrier or diluent wherein the hydralazine hydrochloride is essentially free of phthalazines, hydrazine and metal ions. In addition, a stable sterile aqueous pharmaceutical composition comprising hydralazine hydrochloride in a pharmaceutically acceptable salt or diluent is described that is colorless and has no visible particulate matter.
REFERENCES:
patent: 3321554 (1967-05-01), Zimmerman et al.
patent: 6821974 (2004-11-01), Barbeau
patent: 6825196 (2004-11-01), Barbeau
patent: 2002/0192285 (2002-12-01), Mulye
patent: 2005/0130975 (2005-06-01), Barbeau
patent: 2005/0137397 (2005-06-01), Nelson
patent: 2006/0211982 (2006-09-01), Prestrelski et al.
patent: 2490826 (2010-07-01), None
J. Milton Harris, “Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications.”, Published by Springer, 1992:p. 4; ISBN 0306440784, 9780306440786.
McEvoy et al. (AHFS Drug Information. Bethesda, MD: Authority of the Boards of Directors of the American Society of Hospital Pharmacists, 1994).
Denningston, Philip. Physicians® GenRx. Riverside, CT, Denningston Publishing Inc., 1995.
Remington: The Science and Practice of Pharmacy. Ed. Daniel Limmer. Philadelphia: University of the Science in Philadelphia, 2000. pp. 780-807.
Office Action issued in Canadian Patent Application No. 2,490,826, dated Mar. 6, 2007.
Office Action issued in Canadian Patent Application No. 2,490,826, dated Feb. 1, 2008.
Office Action issued in Canadian Patent Application No. 2,490,826, dated Mar. 23, 2009.
Barbeau Donald
Nelson Deanna J.
Bioniche Teoranta
Kramer & Amado P.C.
Krass Frederick
Simmons Chris E
LandOfFree
Stable hydrazalazine pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable hydrazalazine pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable hydrazalazine pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2710173